Trial Profile
Substance Misuse To Psychosis for Stimulants (SToP-S)--An Early Assertive Pharmacotherapy Intervention Study
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 07 Jul 2023
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Aripiprazole (Primary) ; Paliperidone (Primary) ; Paliperidone (Primary)
- Indications Psychotic disorders; Substance-related disorders
- Focus Therapeutic Use
- Acronyms SToP-S
- 02 Jul 2023 Planned End Date changed from 31 Dec 2023 to 31 May 2025.
- 02 Jul 2023 Planned primary completion date changed from 31 May 2023 to 31 May 2024.
- 05 Sep 2022 Planned End Date changed from 31 Dec 2022 to 31 Dec 2023.